Indonesia vs Peru: HIV-positive TB patients on ART (antiretroviral therapy)
Indonesia
54.0%
in 2024
Peru
57.0%
in 2024
Indonesia rank
138th
Peru rank
137th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Indonesia
- Peru
How they compare
Peru currently reports 57.0% against 54.0% in Indonesia, a difference of 3.0%.
That makes Peru's figure about 1.1 times Indonesia's.
The two have swapped places 1 time across 16 shared years of data; in 2009 it was Indonesia ahead.
Indonesia ranks 138th and Peru ranks 137th of 144 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Peru in 2.
Head to head by decade
| Decade | Indonesia | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.0% | 18.0% | 24.0% | Indonesia |
| 2010s | 36.4% | 60.8% | 24.4% | Peru |
| 2020s | 39.8% | 53.8% | 14.0% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Indonesia or Peru?
- Peru, at 57.0% against 54.0% in Indonesia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Indonesia and Peru?
- 3.0%, with Peru ahead.
- How many years of comparable data are there for Indonesia and Peru?
- 16 years are reported by both, from 2009 to 2024.
- How do Indonesia and Peru rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Indonesia ranks 138th and Peru ranks 137th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.